“…Studies have shown that EUS can identify small metastatic lesions that were not identified on CT, including left lobe liver metastases, perivascular cuffing by tumor, and malignant involvement of celiac ganglia. [18][19][20] The ability to obtain tissue specimens from these sites or from the primary pancreatic mass is increasingly important. Pancreatic mass lesions may be adenocarcinoma, other neoplasms such as neuroendocrine tumors or metastases, or benign conditions such as autoimmune pancreatitis, and these lesions cannot always be differentiated by clinical findings, imaging, and laboratory tests.…”